Weekly Docetaxel versus Every Three 'reeks in Advanced and Metastatic Breast Cancer Patients
Rasha Mohammed Fahmi;
Abstract
Tills work is a comparative prospective randomized study to compare between the efficacy and tolerability of short inter treatment period (weekly docetaxel) and conventional (every three weeks) in advanced pre-and postmenopausal females of breast cancer cases; who attended El-Salam Oncology Center during the period from May 2000 to April2001.
Other data
| Title | Weekly Docetaxel versus Every Three 'reeks in Advanced and Metastatic Breast Cancer Patients | Other Titles | دراسة مقارنة استخدام عقار الدوسيتاكسيل اسبوعيا وكل ثلاثة اسابيع فى حالات سرطان الثدى المتقدم والمنتشر | Authors | Rasha Mohammed Fahmi | Issue Date | 2001 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.